ARTICLE | Company News
Nabi, GlaxoSmithKline deal
November 23, 2009 8:00 AM UTC
Nabi granted GlaxoSmithKline an option for exclusive, worldwide rights to NicVax. The nicotine conjugate vaccine is in Phase III testing to treat nicotine addiction and prevent smoking relapse. GSK a...